EVI launches Bridge-To-Transplant Trial with EVAHEART 2 in the US in Q2, 2018!

Evaheart, Inc. (Houston) announces it has received FDA approval to launch the EVAHEART 2 in a US clinical trial for Bridge-To-Transplant.

Site selection is currently ongoing, with enrollment anticipated by Q2, 2018.